Announced Mon, 29 Jun · 09:39 IST
Alkem Medtech updates Occlutech acquisition with supplementary agreement
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.8%1-day move
₹5425.00
prior close
₹5502.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4+0.3-0.3-0.4+2.8+2.5+1.4+2.8+3.2+3.6+4.2———
Up moveDown movePending
AI summary
Alkem Medtech, wholly owned subsidiary of Alkem Labs, has signed a First Supplementary Agreement on 26 June 2026 to the Share Purchase Agreement dated 6 March 2026, for acquiring at least 51 percent and up to 55 percent equity in Switzerland-based Occlutech Holding AG. This continues earlier disclosures from February and March 2026 on the medtech acquisition.
Likely market impact
Deal progresses as planned, supporting Alkem's move into medtech; final terms and completion still pending.